Literature DB >> 4131162

Enhancement of human lymphocyte transformation by aggregated human gamma globulin.

T D Kinsella.   

Abstract

The effect of heat-aggregated human gamma globulin (aggFII) on the induction of in vitro lymphocyte transformation, measured by the uptake of tritiated thymidine into newly synthesized DNA, was studied with peripheral blood lymphocytes derived from 12 patients with rheumatoid arthritis (RA), six with ankylosing spondylitis (AS), two with systemic lupus erythematosus (SLE), and seven normal subjects. It was found that 200 mug aggFII induced significant transformation of the lymphocytes of eight patients with RA, five with AS, one with SLE, and one normal subject. Neither deaggregated FII nor heat-aggregated human serum albumin induced significant transformation of the lymphocytes of any subject tested. A source of complement appeared necessary to support aggFII-induced blastogenesis, since enhanced transformation occurred only in the presence of fresh plasma. Heat-inactivated plasma and fetal calf serum (FCS), and FCS devoid of hemolytic complement, failed to support enhanced blastogenesis in the presence of aggFII. Since substrates similar to those employed in these studies are present in vivo in the rheumatoid joint, it is suggested that aggFII may enhance intra-articular lymphocyte transformation in subjects with RA.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4131162      PMCID: PMC333096          DOI: 10.1172/JCI107648

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

Review 1.  AUTOANTIBODIES AND DISEASE.

Authors:  H G KUNKEL; E M TAN
Journal:  Adv Immunol       Date:  1964       Impact factor: 3.543

2.  The effects of chemical modifications of human gamma-globulins on their interaction with rheumatoid factors and antibodies.

Authors:  S Bozsoky; E C Franklin
Journal:  Arthritis Rheum       Date:  1966-06

3.  Response to autologous immunoglobulin G in patients with rheumatoid arthritis.

Authors:  M A Chamberlain; C G Shapland; I M Roitt
Journal:  Ann Rheum Dis       Date:  1970-03       Impact factor: 19.103

4.  Failure of lymphocyte transformation in response to gamma-globulins in rheumatoid arthritis.

Authors:  J N Kacaki; W E Bullock; J H Vaughan
Journal:  Lancet       Date:  1969-06-28       Impact factor: 79.321

5.  Induction of DNA synthesis in normal human lymphocyte cultures by antigen-antibody complexes.

Authors:  G Möller
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

6.  Immunofluorescent demonstration of an IgG-B1C complex in synovial lining cells of rheumatoid synovial membrane.

Authors:  T D Kinsella; J Baum; M Ziff
Journal:  Clin Exp Immunol       Date:  1969-02       Impact factor: 4.330

7.  Human lymphocyte transformation induced by anti-gamma globulin factors.

Authors:  R A King; R P Messner; R C Williams
Journal:  Arthritis Rheum       Date:  1969-12

8.  The removal of aggregated and nonaggregated autologous gamma globulin from rheumatoid joints.

Authors:  A J Sliwinski; N J Zvaifler
Journal:  Arthritis Rheum       Date:  1969-10

9.  Breakdown products of C 3 in human synovial fluids.

Authors:  N J Zvaifler
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

10.  International reference preparation of rheumatoid arthritis serum.

Authors:  S G Anderson; M W Bentzon; V Houba; P Krag
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

View more
  3 in total

1.  Physical Characterization and Innate Immunogenicity of Aggregated Intravenous Immunoglobulin (IGIV) in an In Vitro Cell-Based Model.

Authors:  E M Moussa; J Kotarek; J S Blum; E Marszal; E M Topp
Journal:  Pharm Res       Date:  2016-04-01       Impact factor: 4.200

2.  Effects of some anti-rheumatic agents on copper-catalyzed thermal aggregation of gamma globulin.

Authors:  S Kuzuna; S Morimoto; K Kawai
Journal:  Agents Actions       Date:  1979-10

3.  Peripheral T lymphocytes from rheumatoid arthritis patients recognize determinants on light chains and/or Fab fragments of immunoglobulin G.

Authors:  N Radoiu; R P Cleveland; M A Leon
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.